An immunohistochemical investigation showed that high CD3+ or CD8+ TILs in oral cancer were related to an improved prognosis [55], which was confirmed by a systematic review and meta-analysis [56]. The gene discussed is CD8A; the disease is lip and oral cavity carcinoma.